Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 study
Titel:
Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 study
Auteur:
Moretto, Roberto Giordano, Mirella Poma, Anello M. Passardi, Alessandro Boccaccino, Alessandra Pietrantonio, Filippo Tomasello, Gianluca Aprile, Giuseppe Lonardi, Sara Conca, Veronica Granetto, Cristina Frassoldati, Antonio Clavarezza, Matteo Bertolini, Alessandro S. Germani, Marco M. Ugolini, Clara Fontanini, Gabriella Masi, Gianluca Falcone, Alfredo Cremolini, Chiara